Report Highlights
The total market for nanobiotechnology products is $19.3 billion in 2010 and is growing at a compound annual growth rate (CAGR) of 9% to reach a forecast market size of $29.7 billion by 2015.
SCOPE OF REPORT
The study scope includes the major nanotechnology formats that are likely to become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2010 through 2015. Technology issues and market-driving forces are discussed.
Influencing factors, including drug delivery needs, biologic imaging trends, industry structure, and patent trends, are also discussed.
BCC examines nanobiotechnology companies and industry alliances, nanomaterial consumption by end-user industry, and market-driving forces. We profile 115 nanobiotechnology companies.
Analyst Credentials
John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Bergin holds a B.S. degree in Chemistry, an M.S. degree in Biotechnology and a Master of Business Administration. John Bergin is a pseudonym of the author.
- Bioprinting: Technologies and Global Markets (BIO148A).
- Liquid Biopsy Tools, Services and Diagnostics (BIO150A).
- DNA Sequencing: Emerging Technologies and Applications (BIO045F)
- Next Generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126B)
Related Reports
Recent Reports
Global Markets and Technologies for Nanofiltration
The global market for nanofiltration is expected to grow from $1.5 billion in 2024 and is projected to reach $3.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2024 to 2029.
Global Markets and Technologies for Carbon Nanotubes
The global market for carbon nanotubes was valued at $2.0 billion in 2023. The market is projected to grow from $2.3 billion in 2024 to $5.9 billion by 2029, at a compound annual growth rate (CAGR) of 20.6% from 2024 through 2029.
Global Markets and Technologies for Nanofibers
The global market for nanofibers is estimated to increase from $2.9 billion in 2023 to reach $9.4 billion by 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through 2028.
Global Nanotechnology Market
The global market for nanotechnology is estimated to increase from $68.0 billion in 2023 to reach $183.7 billion by 2028, at a compound annual growth rate (CAGR) of 22.0% from 2023 through 2028.
Nanotechnology in Energy Applications
The global nanotechnology in energy applications market should reach $18.8 billion by 2028 from $9.3 billion in 2023 at a compound annual growth rate (CAGR) of 15.0% for the forecast period of 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More